{"description":"All AEs were collected after subjects signed the ICF and up to 30 days from the last dose of study therapy (G-CSF+BL-8040/Placebo). AE were followed by the investigators until their satisfactory resolution or stabilization. AE were recorded and graded according to the latest version of the NCI-CTCAE.\n\nAll-cause mortality was reported across the entire study duration, including the 5 years follow-up phase.","eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":12,"description":"Part 1 (lead-in) period. G-CSF given one time daily s.c. for 5-8 days (Days 1 up to 8) at doses of approximately 10 µg/kg/day but not more than 15 µg/kg/day. BL-8040 1.25 mg/kg s.c. on Day 4 (and Day 6, if needed).\n\nFirst apheresis on Day 5 with up to 3 additional procedures possible until Day 8, as needed.","id":"EG000","otherNumAffected":12,"otherNumAtRisk":12,"seriousNumAffected":1,"seriousNumAtRisk":12,"title":"BL-8040 + G-CSF Part 1"},{"deathsNumAffected":2,"deathsNumAtRisk":80,"description":"Part 2: randomized, double-blinded, placebo-controlled period. G-CSF given one time daily s.c. for 5-8 days (Day 1 up to 8) at doses of approximately 10 µg/kg/day but not more than 15 µg/kg/day. BL-8040 1.25 mg/kg s.c. on Day 4 (and Day 6, if needed).\n\nFirst apheresis on Day 5 with up to 3 additional procedures possible until Day 8, as needed.","id":"EG001","otherNumAffected":77,"otherNumAtRisk":80,"seriousNumAffected":7,"seriousNumAtRisk":80,"title":"BL-8040 + G-CSF (Part 2)"},{"deathsNumAffected":1,"deathsNumAtRisk":42,"description":"Part 2 (randomized, double-blinded, placebo-controlled period). G-CSF given one time daily s.c. for 5-8 days (Day 1 up to 8) at doses of approximately 10 µg/kg/day but not more than 15 µg/kg/day. Placebo 1.25 mg/kg s.c. on Day 4 (and Day 6, if needed).\n\nFirst apheresis on Day 5 with up to 3 additional procedures possible until Day 8, as needed.","id":"EG002","otherNumAffected":35,"otherNumAtRisk":42,"seriousNumAffected":0,"seriousNumAtRisk":42,"title":"Placebo + G-CSF (Part 2)"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":80,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Anaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12,"numEvents":1},{"groupId":"EG001","numAffected":5,"numAtRisk":80,"numEvents":6},{"groupId":"EG002","numAffected":4,"numAtRisk":42,"numEvents":7}],"term":"Arthralgia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":12,"numEvents":4},{"groupId":"EG001","numAffected":14,"numAtRisk":80,"numEvents":17},{"groupId":"EG002","numAffected":6,"numAtRisk":42,"numEvents":10}],"term":"Back pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12,"numEvents":0},{"groupId":"EG001","numAffected":2,"numAtRisk":80,"numEvents":2},{"groupId":"EG002","numAffected":3,"numAtRisk":42,"numEvents":4}],"term":"Musculoskeletal chest pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":12,"numEvents":3},{"groupId":"EG001","numAffected":14,"numAtRisk":80,"numEvents":15},{"groupId":"EG002","numAffected":13,"numAtRisk":42,"numEvents":18}],"term":"Bone pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":80,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Spinal pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":80,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Muscle spasms"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":80,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Ear discomfort"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":80,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Auricular swelling"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":80,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Catheter site bruise"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12,"numEvents":1},{"groupId":"EG001","numAffected":9,"numAtRisk":80,"numEvents":9},{"groupId":"EG002","numAffected":6,"numAtRisk":42,"numEvents":6}],"term":"Catheter site pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12,"numEvents":1},{"groupId":"EG001","numAffected":2,"numAtRisk":80,"numEvents":3},{"groupId":"EG002","numAffected":4,"numAtRisk":42,"numEvents":5}],"term":"Chest pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":12,"numEvents":3},{"groupId":"EG001","numAffected":22,"numAtRisk":80,"numEvents":22},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Injection site erythema"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":80,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Injection site nodule"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":12,"numEvents":14},{"groupId":"EG001","numAffected":40,"numAtRisk":80,"numEvents":47},{"groupId":"EG002","numAffected":2,"numAtRisk":42,"numEvents":3}],"term":"Injection site pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":12,"numEvents":6},{"groupId":"EG001","numAffected":17,"numAtRisk":80,"numEvents":17},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Injection site pruritus"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12,"numEvents":0},{"groupId":"EG001","numAffected":5,"numAtRisk":80,"numEvents":5},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Injection site reaction"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":80,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Injection site urticaria"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12,"numEvents":1},{"groupId":"EG001","numAffected":3,"numAtRisk":80,"numEvents":3},{"groupId":"EG002","numAffected":3,"numAtRisk":42,"numEvents":4}],"term":"Oedema peripheral"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":12,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":80,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Pyrexia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":80,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Constipation"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":80,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Dyspepsia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":12,"numEvents":2},{"groupId":"EG001","numAffected":11,"numAtRisk":80,"numEvents":11},{"groupId":"EG002","numAffected":5,"numAtRisk":42,"numEvents":5}],"term":"Nausea"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12,"numEvents":1},{"groupId":"EG001","numAffected":6,"numAtRisk":80,"numEvents":6},{"groupId":"EG002","numAffected":2,"numAtRisk":42,"numEvents":2}],"term":"Vomiting"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":80,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Electrocardiogram QT prolonged"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":80,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"White blood cell count increased"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12,"numEvents":0},{"groupId":"EG001","numAffected":6,"numAtRisk":80,"numEvents":6},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Hypersensitivity"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":12,"numEvents":3},{"groupId":"EG001","numAffected":0,"numAtRisk":80,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Hypocalcaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":12,"numEvents":2},{"groupId":"EG001","numAffected":11,"numAtRisk":80,"numEvents":11},{"groupId":"EG002","numAffected":5,"numAtRisk":42,"numEvents":5}],"term":"Hypokalaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":80,"numEvents":1},{"groupId":"EG002","numAffected":4,"numAtRisk":42,"numEvents":5}],"term":"Hypomagnesaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12,"numEvents":1},{"groupId":"EG001","numAffected":8,"numAtRisk":80,"numEvents":11},{"groupId":"EG002","numAffected":4,"numAtRisk":42,"numEvents":5}],"term":"Paraesthesia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12,"numEvents":0},{"groupId":"EG001","numAffected":5,"numAtRisk":80,"numEvents":5},{"groupId":"EG002","numAffected":4,"numAtRisk":42,"numEvents":5}],"term":"Headache"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12,"numEvents":0},{"groupId":"EG001","numAffected":5,"numAtRisk":80,"numEvents":6},{"groupId":"EG002","numAffected":3,"numAtRisk":42,"numEvents":7}],"term":"Hypoaesthesia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":80,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Dysphonia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":80,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Paranasal sinus discomfort"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":80,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Dyspnoea"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":12,"numEvents":2},{"groupId":"EG001","numAffected":9,"numAtRisk":80,"numEvents":15},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Erythema"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":12,"numEvents":8},{"groupId":"EG001","numAffected":26,"numAtRisk":80,"numEvents":28},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Pruritus"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":12,"numEvents":2},{"groupId":"EG001","numAffected":7,"numAtRisk":80,"numEvents":7},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Rash"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":80,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Rash maculo-papular"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":12,"numEvents":3},{"groupId":"EG001","numAffected":10,"numAtRisk":80,"numEvents":10},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Urticaria"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12,"numEvents":0},{"groupId":"EG001","numAffected":6,"numAtRisk":80,"numEvents":6},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Dermatitis exfoliative"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":12,"numEvents":4},{"groupId":"EG001","numAffected":0,"numAtRisk":80,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Flushing"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":80,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Hypertension"}],"seriousEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":80,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Injection site reaction"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":80,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Hypersensitivity"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":80,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Bacteremia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":80,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Injection site cellulitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":80,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Platelet count decreased"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":80,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Bladder neoplasm"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":12,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":80,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Hypoxia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":80,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Hypokalaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 20.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":12,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":80,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":42,"numEvents":0}],"term":"Vomiting"}],"timeFrame":"All Adverse Events (AEs) were collected after subjects signed the ICF and up to 30 days from the last dose of study therapy (G-CSF+BL-8040/Placebo)."}